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Cytomegalovirus (CMV) infection is usually asymptomatic in immunocompetent patients.
A mononucleosis-like syndrome may develop in some patients. Various organ involvements
(eg: encephalitis,meningitis, retinitis,myocarditis, pneumonia, hepatitis, enterocolitis, neu-
ritis), which rarely occur in immunocompetent patients, have also been reported. Cutaneous
necrotizing vasculitis caused by CMV infection has been reported very rarely in the litera-
ture. Here, a case with a very rare clinical form of CMV infection, presenting with persistentCytomegalovirus
Vasculitis
Cutaneous
fever and livedo reticularis on the extremities and cutaneous necrotizing vasculitis of the
toes, is described, and the relevant literature is reviewed. This case report aims to highlight
the possibility of CMV infection to be a cause of cutaneous necrotizing vasculitis.
© 2012 Elsevier Editora Ltda.
count (WBC): 8,700/mm3, hemoglobin (Hgb): 9.7 g/dL, hema-
tocrit (Htc): 30%, platelets (PLT): 534,000/mm3, erythrocyte
sedimentation rate (ESR): 70mm/hr, C-reactive protein (CRP):
Open access under CC BY-NC-ND license.Introductıon
Cytomegalovirus (CMV) infection is usually asymptomatic
in immunocompetent patients.1 A mononucleosis-like syn-
drome may develop in some of the patients. Apart from
that, various organ involvements (e.g.: encephalitis, meningi-
tis, retinitis, myocarditis, pneumonia, hepatitis, enterocolitis,
neuritis), which are rare in immunocompetent patients, have
also been reported.2 Cutaneous necrotizing vasculitis caused
by CMV has been reported very rarely.3–5 In this report, a very
rare clinical form of CMV infection, presenting with persis-
tent fever and livedo reticularis on extremities and cutaneous
necrotizing vasculitis of toes, is described, and the literature
regarding this case is reviewed.∗ Corresponding author at: Infectious Diseases and Clinical Microbiolo
Kartal, Istanbul, Turkey.
E-mail address: ferhatarslandr@hotmail.com (F. Arslan).
1413-8670 © 2012 Elsevier Editora Ltda.
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Open access under CC BY-NC-ND licenseCase presentation
A 17 year-old female had been treated with amoxicillin-
clavulunic acid, and clarithromycin for complaints of fever
and cough. Her cough resolved within a month, but the fever
persisted, and she started to present additional symptoms
such as nocturnal sweating, livedo reticularis-like rash on
hands and feet, and weight loss (12% of total body weight).
There were no enlarged peripheral lymph nodes on physi-
cal examination. Laboratory investigation results during the
ﬁrst month of her illness were as follows: white blood cellgy, Lutfı Kirdar Kartal Training and Research Hospital, TR 34863
.
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Fig. 1 – Necrotic appearance of the tip of the second toe of
patient’s right foot with purple to bluish discoloration.
Fig. 2 – Histopathological slide of the biopsy of tip of the
second toe of the patient’s right foot, revealing necrosis in
the epidermis and dermis, and necrotizing vasculitis and
by causingdirect cell injury anddeath or bymeans of immune-
mediated injury via induction of autoimmunity (molecular
mimicry). Other reported mechanisms of vascular injury arebraz j infect d i s .
4mg/L, alanine aminotransferase (ALT): 13 U/L, aspartate
minotransferase (AST): 12 U/L, creatinine kinase (CK): 19 U/L,
otal protein: 8.1mg/dL, albumin: 3.9mg/dl, ANA (antinuclear
ntibody): negative, anti-dsDNA (anti-double-stranded DNA):
egative, urea: 30mg/dL, creatinine: 0.9mg/dl, urinary sedi-
ent: normal. Since this patient had been considered as a
fever of unknownorigin” case andhad the symptomsof fever,
eight loss, and nocturnal sweating, thoracic and abdominal
omputed tomography (CT) scans were performed, along with
one marrow aspiration and biopsy to exclude lymphoma
r any other malignancy. However, these exams revealed no
bnormality. Suspecting the diagnosis of sustained mononu-
leosis syndrome, CMV serology was performed by ELISA.
MV IgM was 7.85 AU/mL (Abbott Architect i1000SR) and CMV
gG was 130.4 AU/mL (Abbott Architect i1000SR), and CMV
gG avidity was 4% (Abbott Architect i1000SR). CMV PCR was
ot initially tested. Human immunodeﬁciency virus (HIV),
pstein-Barr virus (EBV), toxoplasma and parvovirus serology
ere investigated for the differential diagnosis of mononucle-
sis syndrome, as well as hepatitis B virus (HBV) and hepatitis
virus (HCV) serology. Tests for EBV VCA IgM, toxoplasma IgM
nd IgG, anti-HIV, and parvovirus IgM, HBsAg, anti-HBc IgM
nd anti-HCV were all negative.
During the second month of her illness, fever, and
ilateral livedo reticularis on her feet, more prominent
n the left, continued. Repeated blood cultures remained
terile. No vegetations were detected on transthoracic
chocardiography. No abnormality was detected on thoracic
nd abdominal CT. Arterial and venous Doppler ultra-
onography of the upper and lower extremities and MRI
magnetic resonance imaging)-angiography of the aorta and
ts branches were normal. Markers for autoimmune dis-
ases including ANA, anti-ds-DNA, RF (rheumatoid factor),
nti-CCP (anti-cyclic citrullinated peptide), anti-LA (anti-SSB),
nti-RO (anti-SSA), anti-ENA (anti-extractable nuclear anti-
en), Sm-antigen (Smith antigen), anti-ENA U1-RNP (U1-
ibonucleoprotein), anti-cardiolipin IgM and IgG, MPO-ANCA
myeloperoxidase-anti-neutrophil cytoplasmic antibody), p-
NCA (perinuclear-ANCA), c-ANCA (cytoplasmic-ANCA) were
ll negative. CMV IgM was negative, but CMV IgG was >250
U/mL (Abbott Architect i1000SR) with low avidity (CMV IgG
vidity: 4%, low avidity if less than 20%), PCR assay for CMV
as negative. Other laboratory test results were as follows;
BC: 7.200/mm3, Hgb: 8.7 g/dL, Htc: 28.7%, PLT: 524,000/mm3,
SR: 76mm/hr, CRP: 39mg/L (negative if < 3mg/L) and bio-
hemical tests were within normal limits. As any infectious
ocus had not been detected, treatment with methylpred-
isolone 1mg/kg was begun. Although her fever resolved
nd ESR and CRP values decreased to normal levels, the
ip of the second toe of her right foot had become necrotic
Fig. 1). The biopsy of this lesion revealed necrosis in the
pidermis and dermis, necrotizing vasculitis, and occlusive
asculopathy of the small-sized vessels (Fig. 2). Inclusion bod-
es were not observed in the tissue specimen and CMV PCR
as negative. Azathioprine 50mg twice a day and methyl-
rednisolone 48mg was given to the patient. After the ﬁrst
onth of immunosuppressive therapy, necrosis of the toes
ad begun to regress. She had no other systemic signs and
ymptoms, and she is still under follow-up at the outpatient
linic.occlusive vasculopathy of the small vessels.
Discussion
In recent years, some laboratory data regarding the associa-
tion between viral infections and some autoimmune diseases
have been obtained. Particularly, CMV-related conditions are
remarkable. High CMV prevalence in systemic lupus erithe-
matous patients, CMV antigen positivity in synovial ﬂuid of
rheumatoid arthritis patients, and presence of UL94-related
apoptosis in vascular endothelium of systemic sclerosis cases
are some examples.6–8
During the course of viral infections, viruses have been
thought to cause vasculitis and vasculopathy either directly
by replication in the vascular endothelium or indirectly by
induction of autoimmunity.9 Some well-known examples
are intra-synovial deposition of immune complexes against
hepatitis B virus surface antigen or anti-HBsAg in polyarteri-
tis nodosa, and hepatitis C virus-related cryoglobulinemic
vasculitis.10,11 Despite conﬂicting results, studies describing
parvovirus and herpes virus infections to cause temporal
arteritis and giant-cell arteritis have been reported.12
CMV infection causes vascular endothelial damage either
i s . 20
r
1
1
12. Alvarez-Lafuente R, Fernández-Gutiérrez B, Jover JA, et al.
Human parvovirus B19, varicella zoster virus, and human
herpes virus 6 in temporal artery biopsy specimens of
patients with giant cell arteritis: analysis with quantitative484 braz j infect d
pro-coagulant activity increase and blockage of apoptosis in
the endothelium. Favorable clinical response to antiviral and
immunosuppresive treatments in the discussed cases points
out to the possibility of CMV-related endothelial injury to
occur by different mechanisms.9,13,14
Magro CM et al. have reported seven cases that had devel-
oped signs of cutaneous vasculitis after CMV infection. In
these cases, although CMV infection had been conﬁrmed
serologically and virologically by molecular methods, spe-
ciﬁc inclusion bodies and virological evidence could not be
obtained in tissue specimens. Good clinical response to antivi-
ral therapy was reported for all but one patient.3 In the case
described by Varani et al., sustained CMV mononucleosis was
reported to be responsible for active endothelial injury and
Wegener’s granulomatosis by inducing autoimmune response.
In the same case report, it was postulated that the accom-
panying polymicrobial urinary tract infection together with
sustained CMV infection might have induced the vasculytic
process in the kidneys. Nevertheless, this patient did not have
any sign of localized infection supporting this hypothesis.15
Meyer et al. have reported that gancyclovir treatment alone,
without intense immunosuppressive therapy, was success-
ful in their patient with ANCA-positive systemic necrotizing
vasculitis, which developed after systemic CMV infection.16
Besides, in the case reported by Nolan et al., treated with
cyclophosphamide for Wegener’s granulomatosis, although
the systemic signs had resolved and the antibody titers had
decreased, the foot ulcer had progressed. Gancyclovir ther-
apy could only be started after the detection of CMV inclusion
bodies in the biopsy specimen and good clinical outcome was
reported.17
McCormick et al. demonstrated that digital vasculitis devel-
oping in a patient with rheumatoid arthritis was caused by
immune-complexes against CMV antigen.18 Kuroda et al. have
claimed the immune-complexes, produced against CMV anti-
gen deposited in the vascular endothelium, to be responsible
for acute hemorrhagic edema that developed during acute
CMV infection in their patient, but they could not demonstrate
the presence of CMV inclusions.4
In the current patient, presenting with persistent fever
and livedo reticularis, radiological and immunological inves-
tigation did not reveal any signs of vascular pathology or
connective tissue disease. Despite the very good response of
fever and acute phase reactants to steroid therapy, the livedo
reticularis, predominant in lower extremities, and the necrotic
lesions that ﬁrst developed in the right second toe and later
in the toes of the left foot did not regress. Biopsy specimen
showed the signs of necrotizing vasculitis, but there were no
systemic signs and symptoms. Laboratory ﬁndings were com-
pletely normal. Except for autoimmune necrotizing vasculitis
induced by CMV infection, no other rheumatologic pathol-
ogy was detected. Fever persisting more than two months
and the subsequent localized cutaneous vasculitis had been
interpreted as complications of sustained CMV infection. Even
though the serological tests (CMV IgM and IgG avidity) per-
formed at the beginning and in the second month of the
clinical coursewere consistentwith acute CMV infection, CMV
DNA by PCR assay was not demonstrated either in blood or
in tissues. This is why antiviral therapy could not have been
given to the patient.12;16(5):482–485
Conclusion
In conclusion, during the course of CMV infection, signs of
localized or systemic vasculitis may develop. In light of pre-
viously reported cases, it has been shown that some patients
have beneﬁted from antiviral therapy while others beneﬁted
from anti-inﬂammatory treatment. In order to decide which
therapy would offer a better outcome for a given patient
withCMV-related vasculitis, controlled studies includingmore
patients are necessary.
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